Earnings Call · Q2 FY2022·2022-08-06

Q2 22EPS 0.00%·Rev n/aQ1 22EPS +4.61%·Rev n/aQ4 21EPS -12.98%·Rev n/aQ3 21EPS -22.56%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Michael Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — General Manager of Oncology

+4.1%1d on move date+4.2% vs SPY3d+6.5%5d+12.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access